Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

KRN 5500 MeSH Supplementary Concept Data 2026


MeSH Supplementary
KRN 5500
Unique ID
C092296
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C092296
Entry Term(s)
6-(4-deoxy-4-((2E,4E)-tetradecadienoylglycyl)amino-L-glycero-b-L-mannoheptopyranosyl)amino-9H-purine
KRN-5500
KRN5500
Pharm Action
Antineoplastic Agents
Protein Synthesis Inhibitors
Registry Numbers
8VH13L5K20
Heading Mapped to
Purine Nucleosides
Frequency
26
Note
a derivative of spicamycin with a wide range of antitumor activity against human cancer cell lines; structure given in first source
Source
Cancer Res 1995 Mar 1;55(5):1075-9
Date Introduced
1995/03/29
Last Updated
2018/09/24
KRN 5500 Preferred
6-(4-deoxy-4-((2E,4E)-tetradecadienoylglycyl)amino-L-glycero-b-L-mannoheptopyranosyl)amino-9H-purine Broader
page delivered in 0.007s